Document:

Exhibit
10.1

 

AMENDMENT 2004-I

 

BECKMAN COULTER, INC.

EXECUTIVE DEFERRED COMPENSATION PLAN

 

WHEREAS, Beckman Coulter,
Inc. (the “Company”), a Delaware corporation, maintains the Beckman Coulter,
Inc. Executive Deferred Compensation Plan (the “Plan”); and

 

WHEREAS, the Company
previously amended the Plan to provide that any premium units credited under
the Plan with respect to deferrals of compensation on and after April 1,
2004 be settled in cash as opposed to shares of Company stock;

 

WHEREAS, the Company now
desires to amend the Plan to provide that any premium units credited under the
Plan with respect to deferrals of compensation on and after April 1, 2004
shall be settled in Company stock and charged against the applicable share
limits of a Company equity compensation plan;

 

WHEREAS, the Company has
the right to amend the Plan;

 

NOW, THEREFORE,
Section 6.1(b) of the Plan is hereby amended to read as follows, effective
immediately:

 

“(b)                   Manner of
Distribution.  The amount to be paid to
the Participant shall be the vested portion of the Participant’s Accounts.  The form of payment of any distribution
required pursuant to this Plan (including, for this purpose, any distribution
in respect of a withdrawal pursuant to Section 6.3) shall be determined as
follows:

 

(i)  Amounts
not denominated as Stock Units as of the date of distribution shall be paid in
cash and valued as of the date the amount of the distribution is determined.

 

(ii)  If, as of
the date of distribution, benefits continue to be denominated as Stock Units,
then the benefit attributable to the Stock Units credited to a Participant’s
Accounts shall, subject to following provisions of this clause (ii),

 

1

 

be distributed in an equal number of shares of Common
Stock.  Shares of Common Stock that are
delivered in payment of Premium Units (including Dividend Equivalent Stock
Units) that are credited in respect of a Bonus and/or Sign-On Credit on or
after April 1, 2004 shall be charged against the applicable share limits
of a Company equity compensation plan. 
To the extent that an insufficient number of shares of Common Stock
remain available under any such plan to cover a payment of such Stock Units in
the form of Common Stock, the Stock Units that exceed the number of shares of
Common Stock then available within the applicable share limits of such plan
shall be settled in cash.  In addition,
any fractional Stock Unit interest shall be settled in cash.  The settlement amount of any Stock Unit to
be settled in cash shall equal the Fair Market Value of a share of Common Stock
determined as of the date used by the trustee of the Trust to determine the
taxable income reportable with respect to such distribution.”

 

IN WITNESS WHEREOF, this
Amendment 2004-I is hereby adopted this 7th day of October, 2004.

 

 

	
   

  	
  BECKMAN COULTER, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By 

  	
  /s/ Fidencio M. Mares

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  Its

  	
  Vice President, Human
  Resources and

  	
   

  
	
   

  	
   

  	
  Corporate
  Communications

  	
   

  

 

2Exhibit 10.82
 
EMPLOYMENT AGREEMENT
 
THIS EMPLOYMENT AGREEMENT (this “Agreement”) made as of June 30, 2004, between Implant Sciences Corporation, a Massachusetts corporation (the “Company”), and Anthony J. Armini, an individual residing at 13 Skytop Drive, Manchester, MA 01944 (the “Employee”),
 
WITNESSETH THAT:
 
WHEREAS, the Company desires to employ Employee as one of its senior executive officers for the period and upon and subject to the terms herein provided; and
 
WHEREAS, the Company desires to be assured that Employee will not compete with the Company for the period and within the geographical areas hereinafter specified; and
 
WHEREAS, Employee is willing to agree to be employed by the Company for the period and upon and subject to the terms herein provided;
 
NOW, THEREFORE, in consideration of the premises, the parties hereto covenant and agree as follows:
 
Section 1. Term of Employment;
 
(a)          Position.  The Company agrees to employ Employee from the date hereof until June 30, 2007, as President and Chief Executive Officer, with the responsibilities normally associated with such position.
 
(b)         Term.  This Agreement shall be automatically renewed for successive period of three years, unless the Employee or the Company gives the other party not less than three (3)  months written notice of non-renewal.
 
(c)          Compensation.  The Company will pay Employee for his services during the term of the Employee’s employment hereunder at an annual rate of up to Two Hundred Thousand Dollars ($200,000), unless a higher amount is authorized by the Compensation Committee, payable in arrears, in equal installments, in accordance with standard Company practice, but in any event not less often than monthly, subject only to such payroll and withholding deductions as are required by law and up to an additional Ten Thousand Dollars ($10,000) of salary in kind.  This salary will be subject to annual review and increase (but not decrease) by the Board of Directors of the Company or the Compensation Committee thereof.  The employee may choose to have a salary less than these limits if he chooses to do so for business reasons.
 
(d)         Bonus.  The Employee may receive an annual bonus, the awarding and the amount of which shall be determined by the Company’s Board of Directors in its sole discretion.
 
(e)          Stock Options.  Stock Options may be granted in the amount authorized by the Compensation Committee.

 

 

Section 2. Office and Duties. Employee shall have the usual duties of President and Chief Executive Officer and shall have responsibility, subject to the Board of Directors of the Company, for participating in the management and direction of the Company’s business and operations and shall perform such specific other tasks, consistent with the Employee’s position as President and Chief Executive Officer, as may from time to time be assigned to the Employee by the Board of Directors.  Employee shall devote substantially all of his business time, labor, skill, undivided attention, and best ability to the performance of his duties hereunder in a manner which will faithfully and diligently further the business and interests of the Company.  During the term of his employment, Employee shall not directly or indirectly pursue any other business activity competing with that of the Company or requiring any significant outlay of time, without the Company’s prior written consent. Employee agrees that he will travel to whatever extent is reasonably necessary in the conduct of the Company’s business.
 
Section 3.  Expenses. Employee shall be entitled to reimbursement for expenses incurred by him in connection with the performance of his duties hereunder upon receipt of vouchers therefor in accordance with such procedures as the Company has heretofore or may hereafter establish.
 
Section 4.  Vacation During Employment. Employee shall be entitled to such reasonable vacations as may be allowed by the Company in accordance with general practices to be established, but in any event not less than four (4) weeks during each twelve (12) month period.
 
Section 5.  Additional Benefits. Nothing herein contained shall preclude Employee, to the extent he is otherwise eligible, from participation in all group insurance programs or other fringe benefit plans which the Company may hereafter in its sole and absolute discretion make available generally to its employees, but the Company shall not be required to establish or maintain any such program or plan.
 
Section 6.  Termination of Employment. Notwithstanding any other provision of this Agreement, Employee’s employment may be terminated:
 
(a) By the Company in the event of his failure, refusal or inability to perform the services required of him hereby, or to carry out any proper direction by the Company with respect to the services to be rendered by him hereunder or the manner of rendering such services, his willful misconduct in the performance of his duties hereunder, or his conviction of a crime involving moral turpitude.
 
(b) By the Company upon thirty (30) days’ notice to Employee if he should be prevented by illness, accident or other disability (mental or physical) from discharging his duties hereunder for one or more periods totaling three (3) months during any consecutive twelve (12) month period.
 
(c) By either the Company or Employee for any material breach by the other of the terms hereof, but only if such breach continues for ten (10) days (or such longer period as is reasonably required to cure such breach with diligent and good faith effort) after written notice to the other specifying the breach relied on for such termination.
 
(d) In the event of Employee’s death during the term of his employment, the Company’s obligation to pay further compensation hereunder shall cease forthwith, except that Employee’s legal

 

 

representative shall be
entitled to receive his fixed compensation for the period up to last month
after the month in which such death shall have occurred.

 
(e) By the Company without cause upon not less than thirty (30) days’ written notice in which event the Company shall pay to Employee an amount equal to twelve (12) months salary specified based on the annual in the second sentence of Section 1.
 
Section 7. Disclosure and Assignment of Intellectual Property. Employee shall promptly disclose to the Company and any successor or assign of the Company, and grant to the Company, and its successors and assigns (without any separate remuneration or compensation other than that received by him from time to time in the course of his employment) his entire right, title and interest throughout the world in and to all research, information, inventions, designs, procedures, developments, discoveries, improvements, patents and applications therefor, trademarks and applications therefor, copyrights and applications therefor, trade secrets, drawings, plans, systems, methods, specifications, and all other manufacturing, engineering, technical, research and development data and know-how (herein sometimes “Intellectual Property”) made, conceived, developed and/or acquired by him solely or jointly with others during the period of his employment with the Company or within one year thereafter, which relate to the manufacture, production or processing of any products developed or sold by the Company during the term of this Agreement or which are within the scope of or usable in connection with the Company’s business as it may, from time to time, hereafter be conducted or proposed to be conducted. (It is understood and agreed that Employee has heretofore disclosed to the Company, and assigned to it, all Intellectual Property now known to him over which he has any control.) Employee agrees to execute all appropriate patent applications securing all United States and foreign patents on all Intellectual Property, and to do, execute and deliver any and all acts and instruments that may be necessary or proper to vest all Intellectual Property in the Company or its nominee or designee and to enable the Company, or its nominee or designee, to obtain all such patents; and Employee agrees to render to the Company, or its nominee or designee, all such assistance as it may require in the prosecution of all such patent applications and applications for the re-issue of such patents, and in the prosecution or defense of all interferences which may be declared involving any of said patent applications or patents, but the expense of all such assignments and patent applications, or all other proceedings referred to herein above, shall be borne by the Company. Employee shall be entitled to fair and reasonable compensation for any such assistance requested by the Company or its nominee or designee and furnished by him after the termination of his employment.
 
Section 8. Confidentiality. Employee shall not, either during the period of his employment with the Company or thereafter, reveal or disclose to any person outside the Company or use for his own benefit, without the Company’s specific written authorization, whether by private communication or by public address or publication or otherwise, any information not already lawfully available to the public concerning any Intellectual Property, or any marketing technique or cost method, or any customer, mailing or supplier list, whether or not supplied by the Company, and whether or not made, developed and/or conceived by Employee or by others in the employ of the Company. All originals and copies of any of the foregoing, relating to the business of the Company, however and whenever produced, shall be the sole property of the Company, not to be removed from the premises or custody of the Company without in each instance first obtaining written consent or authorization of the Company. Upon the termination of Employee’s employment in any manner or for any reason, Employee shall promptly surrender to the Company all copies of any of the foregoing, together with any other documents, materials, data, information and equipment

 

 

belonging to or relating to the
Company’s business and in his possession, custody or control, and Employee
shall not thereafter retain or deliver to any other person, any of the foregoing
or any summary or memorandum thereof.

 
Section 9. Restriction. The Company has invested and may in the future be required to invest substantial sums of money, directly or indirectly, to continue and expand the business heretofore conducted by it and in connection therewith, and as Employee recognizes that the Company would be substantially injured by Employee disclosing to others, or by Employee using for his own benefit, any Intellectual Property or any of the other types of information referred to in Section 8 or other confidential or secret information he has obtained or shall obtain as an employee of the Company, or which he may now possess and which he has made available to the Company, Employee agrees that during the period of his employment hereunder and for a period ending two (2) years after the term of this Agreement:
 
(a) Neither he nor any member of his family will be interested, directly or indirectly, as an investor in any other business or enterprise in the United States or Canada or any other location where we sell, similar to that of the Company or in competition with the Company (except as an investor in securities listed on a national securities exchange or actively traded over the counter so long as such investments are in amounts not more than 1% as compared to his total investments or to the aggregate of the outstanding securities of the issuer of the same class or issue); and
 
(b) He will not, directly or indirectly, for his own account or as employee, officer, director, partner, joint venturer or otherwise, engage within the United States or elsewhere, in any phase of the business of providing surface modification services to the medical device and semiconductor industries or the development and/or manufacturing of explosives detection equipment or any other business the Company ins engaged in during employment or contemplating entering at time of termination of employment..
 
Employee and the Company are of the belief that the period of time and the area herein specified are reasonable, in view of the nature of the business in which the Company is engaged and proposes to engage, the state of its product development and Employee’s knowledge of this business. However, if such period or such area should be adjudged unreasonable in any judicial proceeding, then the period of time shall be reduced by such number of months or such area shall be reduced by elimination of such portion of such area, or both, as are deemed unreasonable, so that this covenant may be enforced in such area and during such period of time as is adjudged to be reasonable.
 
Section 10. Notices. All notices and other communications hereunder shall be in writing and shall be deemed to have been given when delivered or three (3) days after mailing if mailed by first-class, registered or certified mail, postage prepaid, addressed (a) if to Employee, at 13 Skytop Drive, Manchester, MA 01944, and/or to such other person(s) or address(es) as Employee shall have furnished to the Company in writing; and (b) if to the Company, Implant Sciences Corporation, 107 Audubon Road #5, Wakefield, MA 01880, or to such other person(s) or address(es) as the Company shall have furnished to Employee in writing.
 
Section 11. Assignability. In the event that the Company shall be merged with, or consolidated into, any other corporation, or in the event that it shall sell and transfer substantially all of its assets to another corporation, the terms of this Agreement shall inure to the benefit of, and be assumed

 

 

by, the corporation resulting
from such merger or consolidation, or to which the Company’s assets shall be
sold and transferred.

 
Section 12. Entire Agreement. This Agreement contains the entire agreement between the Company and Employee with respect to the subject matter thereof and there have been no oral or other agreement of any kind whatsoever as a condition precedent or ) inducement to the signing of this Agreement or otherwise concerning this Agreement or the subject matter hereof., or a settlement agreement between parties otherwise authorized by the producing party.
 
Section 13. Expenses. Each party shall pay its own expenses incident to the performance or enforcement of this Agreement, including all fees and expenses of its counsel for all activities of such counsel undertaken pursuant to this Agreement, except as otherwise herein specifically provided.
 
Section 14. Equitable Relief. Employee recognizes and agrees that the Company’s remedy at law for any breach of the provisions of Sections 7, 8 or 9 hereof would be inadequate, and he agrees that for breach of such provisions, the Company shall, in addition to such other remedies as may be available to it at law or in equity or as provided in this Agreement, be entitled to injunctive relief and to enforce its rights by an action for specific performance to the extent permitted by law. Should Employee engage in any activities prohibited by this Agreement, he agrees to pay over to the Company all compensation, remunerations or moneys or property of any sort received in connection with such activities; such payment shall not impair any rights or remedies of the Company or obligations or liabilities of Employee which such parties may have under this Agreement or applicable law.
 
Section 15. Waivers and Further Agreements. Any waiver of any terms or conditions of this Agreement shall not operate as a waiver of any other breach of such terms or conditions or any other term or condition, nor shall any failure to enforce any provision hereof operate as a waiver of such provision or of any other provision hereof; provided, however, that no such written waiver, unless it, by its own terms, explicitly provides to the contrary, shall be construed to effect a continuing waiver of the provision being waived and no such waiver in any instance shall constitute a waiver in any other instance or for any other purpose or impair the right of the party against whom such waiver is claimed in all other instances or for all other purposes to require full compliance with such provision. Each of the parties hereto agrees to execute all such further instruments and documents and to take all such further action as the other party may reasonably require in order to effectuate the terms and purposes of this Agreement.
 
Section 16. Amendments. This Agreement may not be amended, nor shall any waiver, change, modification, consent or discharge be effected except by an instrument in writing executed by or on behalf of the party against whom enforcement of any waiver, change, modification, consent or discharge is sought.
 
Section 17. Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument, and in pleading or proving any provision of this Agreement, it shall not be necessary to produce more than one of such counterparts.

 

 
Section 18. Section Headings. The headings contained in this Agreement are for reference purposes only and shall not in any way affect the meaning or interpretation of this Agreement.
 
Section 19.  General Provisions.
 
(a) Employee further agrees that his obligations under Sections 7, 8 and 9 of this Agreement shall be binding upon him irrespective of the duration of his employment by the Company, the reasons for any cessation of his employment by the Company, or the amount of his compensation and shall survive the termination of this Agreement (whether such termination is by the Company, by Employee, upon expiration of this Agreement or otherwise).
 
(b) Employee represents and warrants to the Company that he is not now under any obligations to any person, firm or corporation, and has no other interest which is inconsistent or in conflict with this Agreement, or which would prevent, limit or impair, in any way, the performance by him of any of the covenants or his duties in his said employment.
 
Section 20. Gender. Whenever used herein, the singular number shall include the plural, the plural shall include the singular, and the use of any gender shall include all genders.
 
Section 21. Governing Law. This Agreement shall be governed by and construed and enforced in accordance with the law (other than the law governing conflict of law questions) of the Commonwealth of Massachusetts.
 
IN WITNESS WHEREOF, the parties have executed or caused to be executed this Agreement as of the date first above written.
 

	IMPLANT SCIENCES CORPORATION

	 
	 
	 

	 
	 
	 

	By:
	 
	 
	 

	 
	Diane J. Ryan
	Employee

	 
	Chief Financial Officer
	 

	 
	 
	 

	 
	 
	 

	 
	 
	 
	 

	 
	Gerald Entine
	 

	 
	Chairman of Compensation Committee

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00072-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00072-of-00352.parquet"}]]